CG
LMNL

Cutler Group’s Liminal BioSciences Inc. Common Shares LMNL Stock Holding History

Cutler Group’s Portfolio LMNL Stock Details LMNL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-100
Closed -$2K – 6380
2021
Q3 		$2K Hold
100
– – ﹤0.01% 5162
2021
Q2 		$1K Buy
+100
New +$4.36K ﹤0.01% 5509

Other funds holding LMNL

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
ECM
Estabrook Capital Management New York $685M AUM 26.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Cutler Group's LMNL Position: Q4 2021 in Review

Cutler Group sold out of Liminal BioSciences Inc. Common Shares (LMNL) in Q4 2021, closing a stake of 110 shares — an estimated $2K sold.

Cutler Group first reported a position in LMNL in Q3 2021 and held it in 1 quarter. The position peaked at $2K in Q3 2021. 18 funds tracked by Wall St. Rank hold LMNL as of Q4 2021.

  • Cutler Group reported no remaining Liminal BioSciences Inc. Common Shares position as of Q4 2021 after selling out during the quarter.
  • Cutler Group sold 110 Liminal BioSciences Inc. Common Shares shares in Q4 2021, an estimated $2K.
  • Cutler Group first reported a position in Liminal BioSciences Inc. Common Shares in Q3 2021 and held it in 1 quarter.
  • Cutler Group's Liminal BioSciences Inc. Common Shares position peaked at $2K in Q3 2021.
  • 18 funds tracked by Wall St. Rank held Liminal BioSciences Inc. Common Shares as of Q4 2021.

Based on Cutler Group's 13F filing for Q4 2021, filed 18 Jan 2022.